Screener
Pacira BioSciences, Inc. PCRX Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $192.4M+6.2% | $177.38M+5.0% | $196.87M+5.1% | $179.52M+6.5% | $181.1M+1.7% | ||
| $44.16M+8.1% | $36.41M+6.1% | $40.3M+1.0% | $34.28M-11.8% | $40.87M-7.7% | ||
| $148.24M+5.7% | $140.96M+4.7% | $156.57M+6.2% | $145.24M+12.0% | $140.23M+4.8% | ||
| 77%-0.4pp | 79.5%-0.2pp | 79.5%+0.8pp | 80.9%+4.0pp | 77.4%+2.3pp | ||
| $30.24M+7.2% | $28.07M+10.8% | $37.45M+56.7% | $25.97M+35.9% | $28.2M+38.7% | ||
| $91.81M+3.6% | $93.94M+8.3% | $101.61M+27.6% | $91.8M+23.5% | $88.58M+30.0% | ||
| $188.13M+9.0% | $170.47M+2.1% | $194.53M+19.7% | $173.15M-43.8% | $172.6M+15.2% | ||
| $4.27M-49.8% | $6.9M+247% | $2.34M— | $6.36M+105% | $8.5M-69.9% | ||
| 2.2%-2.5pp | 3.9%+2.7pp | 1.2%— | 3.5%+86.3pp | 4.7%-11.2pp | ||
| $3.62M-22.9% | $3.7M-19.2% | $3.89M-16.8% | $4.28M-8.7% | $4.7M+20.9% | ||
| -$1.71M+83.6% | -$1.9M-128% | -$1.77M-315% | $3.16M+371% | -$10.43M-225% | ||
| $2.56M+233% | $5M-42.6% | $571K— | $9.52M+107% | -$1.93M-105% | ||
| -$2.1M-172% | $2.08M-46.5% | —— | $4.09M-11.2% | $2.92M-83.5% | ||
| $4.65M+196% | $2.92M-39.4% | $1.64M— | $5.43M+104% | -$4.85M-126% | ||
| 2.4%+5.1pp | 1.6%-1.2pp | 0.8%— | 3%+88.1pp | -2.7%-13.3pp | ||
| $0.12+209% | $0.07-30.0% | $0.04— | $0.12+104% | -$0.11-128% | ||
| $25.56M-28.6% | $28.23M+21.9% | $23.68M— | $27.55M+123% | $35.82M-24.0% | ||
| 13.3%-6.5pp | 15.9%+2.2pp | 12%— | 15.3%+86.1pp | 19.8%-6.7pp | ||
| $4.27M-49.8% | $6.9M+247% | $2.34M— | $6.36M+105% | $8.5M-69.9% |
FAQ
- What is Pacira BioSciences, Inc.'s revenue?
- Pacira BioSciences, Inc. (PCRX) generated $746.2M in revenue over the trailing twelve months, up 5.7% year over year.
- Is Pacira BioSciences, Inc. profitable?
- Pacira BioSciences, Inc. reported $14.6M in net income over the trailing twelve months, a 2.0% net margin.
- What are Pacira BioSciences, Inc.'s profit margins?
- Gross margin is 79.2% and operating margin is 2.7%, with a 2.0% net margin.
- What is Pacira BioSciences, Inc.'s earnings per share?
- Pacira BioSciences, Inc.'s diluted EPS over the trailing twelve months is $0.35.
- Where does Pacira BioSciences, Inc.'s income statement data come from?
- Every line is extracted from Pacira BioSciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
